Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 2
Submit an article Journal homepage
402
Views
7
CrossRef citations to date
0
Altmetric
Review

Improving the treatment of patients with diabetes using insulin analogues: current findings and future directions

Eveline LefeverDepartment of Endocrinology, University Hospitals Leuven, Leuven, BelgiumView further author information
,
Joke VlieberghDepartment of Endocrinology, University Hospitals Leuven, Leuven, BelgiumView further author information
&
Chantal MathieuDepartment of Endocrinology, University Hospitals Leuven, Leuven, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4055-5233View further author information
ORCID Icon
Pages 155-169 | Received 01 Sep 2020, Accepted 24 Nov 2020, Published online: 18 Jan 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Peter Novodvorský & Martin Haluzík. (2022) An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus. Expert Opinion on Drug Safety 21:3, pages 349-361.
Read now

Articles from other publishers (6)

Esra Ayan & Hasan DeMirci. (2023) A Brief Atlas of Insulin. Current Diabetes Reviews 19:6.
Crossref
Aya Torii-Goto, Kana Hirai, Yuri Inukai, Yoshimi Hoshina, Kazumi Shiomi, Junko Ito & Masae Yoshikawa. (2023) Investigation of appropriate needle length considering skin thickness with the real injection posture for insulin injections in diabetic patients. Journal of Pharmaceutical Health Care and Sciences 9:1.
Crossref
Tim Heise, Carolina Piras de Oliveira, Rattan Juneja, Anderson Ribeiro, Farai Chigutsa & Thomas Blevins. (2022) What is the value of faster acting prandial insulin? Focus on ultra rapid lispro. Diabetes, Obesity and Metabolism 24:9, pages 1689-1701.
Crossref
Xiaohong Zhang, Xuezhen Zhu, Xiaoyang Bi, Jiguang Huang & Lijuan Zhou. (2022) The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides. International Journal of Molecular Sciences 23:14, pages 7793.
Crossref
Hailey Saunders, Ba’ Pham, Desmond Loong, Sujata Mishra, Huda M. Ashoor, Jesmin Antony, Nazia Darvesh, Silkan K. Bains, Margaret Jamieson, Donna Plett, Srushhti Trivedi, Catherine H. Yu, Sharon E. Straus, Andrea C. Tricco & Wanrudee Isaranuwatchai. (2022) The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review. Value in Health 25:7, pages 1235-1252.
Crossref
Grazia Aleppo, Bruce Bode & Anders L Carlson. (2022) Can Faster Aspart be Used to Optimize Glycemic Control With Insulin Pump Therapy? From Expectations to Lessons Learned After a Year of Use in the United States. Clinical Diabetes.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.